rs112171353
Positions:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2
The NM_032415.7(CARD11):c.1260G>A(p.Glu420=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00129 in 1,614,282 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0068 ( 12 hom., cov: 32)
Exomes 𝑓: 0.00071 ( 9 hom. )
Consequence
CARD11
NM_032415.7 synonymous
NM_032415.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.18
Genes affected
CARD11 (HGNC:16393): (caspase recruitment domain family member 11) The protein encoded by this gene belongs to the membrane-associated guanylate kinase (MAGUK) family, a class of proteins that functions as molecular scaffolds for the assembly of multiprotein complexes at specialized regions of the plasma membrane. This protein is also a member of the CARD protein family, which is defined by carrying a characteristic caspase-associated recruitment domain (CARD). This protein has a domain structure similar to that of CARD14 protein. The CARD domains of both proteins have been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. When expressed in cells, this protein activated NF-kappaB and induced the phosphorylation of BCL10. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 7-2937118-C-T is Benign according to our data. Variant chr7-2937118-C-T is described in ClinVar as [Benign]. Clinvar id is 473927.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=3.18 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00679 (1034/152390) while in subpopulation AFR AF= 0.0232 (964/41598). AF 95% confidence interval is 0.022. There are 12 homozygotes in gnomad4. There are 485 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CARD11 | NM_032415.7 | c.1260G>A | p.Glu420= | synonymous_variant | 9/25 | ENST00000396946.9 | NP_115791.3 | |
CARD11 | NM_001324281.3 | c.1260G>A | p.Glu420= | synonymous_variant | 10/26 | NP_001311210.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CARD11 | ENST00000396946.9 | c.1260G>A | p.Glu420= | synonymous_variant | 9/25 | 1 | NM_032415.7 | ENSP00000380150 | P1 | |
CARD11 | ENST00000698637.1 | n.1586G>A | non_coding_transcript_exon_variant | 9/24 | ||||||
CARD11 | ENST00000698654.1 | n.1519G>A | non_coding_transcript_exon_variant | 9/10 | ||||||
CARD11 | ENST00000698662.1 | n.1460G>A | non_coding_transcript_exon_variant | 9/10 |
Frequencies
GnomAD3 genomes AF: 0.00672 AC: 1024AN: 152272Hom.: 11 Cov.: 32
GnomAD3 genomes
AF:
AC:
1024
AN:
152272
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00194 AC: 488AN: 251430Hom.: 6 AF XY: 0.00141 AC XY: 192AN XY: 135896
GnomAD3 exomes
AF:
AC:
488
AN:
251430
Hom.:
AF XY:
AC XY:
192
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000713 AC: 1043AN: 1461892Hom.: 9 Cov.: 32 AF XY: 0.000582 AC XY: 423AN XY: 727246
GnomAD4 exome
AF:
AC:
1043
AN:
1461892
Hom.:
Cov.:
32
AF XY:
AC XY:
423
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00679 AC: 1034AN: 152390Hom.: 12 Cov.: 32 AF XY: 0.00651 AC XY: 485AN XY: 74518
GnomAD4 genome
AF:
AC:
1034
AN:
152390
Hom.:
Cov.:
32
AF XY:
AC XY:
485
AN XY:
74518
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Severe combined immunodeficiency due to CARD11 deficiency;C4551967:BENTA disease Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at